It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Background. The World Health Organization (WHO) tuberculosis (TB) symptom screening instrument (WHO-TB) can ide.jpegy human immunodeficiency virus (HIV)-infected individuals at low risk of tuberculosis (TB); however, many patients report WHO-TB symptoms and require further TB investigations. We hypothesized that further clinical scoring could classify subjects with a positive WHO-TB screening result (WHO-TB+) for the likelihood of TB.
Methods. HIV-infected adults eligible to initiate antiretroviral therapy (ART) were recruited and prospectively followed at 5 Ethiopian health centers. Irrespective of symptoms, all participants underwent sputum bacteriological testing for TB. Symptoms, physical findings, hemoglobin, and CD4 cell count results were compared between subjects with and those without bacteriologically confirmed TB. Variables associated with TB in WHO-TB+ individuals were used to construct a scoring algorithm with multiple logistic regression analysis.
Results. Among 812 participants, 137 (16.9%) had TB. One hundred fifty-nine persons (20%) had a negative WHO-TB screen, 10 of whom had TB (negative predictive value [NPV], 94% [95% confidence interval {CI}, 90%–97.5%]). For WHO-TB+ subjects, the following variables were independently associated with TB, and were assigned 1 point each in the clinical scoring algorithm: cough, Karnofsky score ≤80, mid-upper arm circumference <20 cm, lymphadenopathy, and hemoglobin <10 g/dL. Among subjects with 0–1 points, 20 of 255 had TB (NPV, 92% [95% CI, 89%–95%]), vs 19 of 34 participants with ≥4 points (positive predictive value, 56% [95% CI, 39%–73%]). The use of WHO-TB alone ide.jpegied 159 of 784 (20%) with a low risk of TB, vs 414 of 784 (53%) using WHO-TB followed by clinical scoring (P< .001). The difference in proportions of confirmed TB in these subsets was nonsignificant (6.3% vs 7.2%; P= .69).
Conclusions. Clinical scoring can further classify HIV-infected adults with positive WHO-TB screen to assess the risk of TB, and would reduce the number of patients in need of further TB investigations before starting ART.
Clinical Trials Registration. NCT01433796.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Infectious Disease Research Unit, Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden; Ministry of Health, Addis Ababa, Ethiopia
2 Infectious Disease Research Unit, Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden
3 Clinical Microbiology Unit, Department of Laboratory Sciences, Lund University, Malmö
4 Department of Medical Microbiology, Faculty of Health Sciences, Linköping University; Department of Clinical Microbiology and Infectious Diseases, Kalmar County Hospital
5 Infectious Disease Research Unit, Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden; Regional Department of Infectious Disease Control and Prevention, Malmö, Sweden
6 Oromia Regional Health Bureau
7 International Center for AIDS Care and Treatment Programs–Ethiopia, Columbia University Mailman School of Public Health, Addis Ababa, Ethiopia
8 Department of Laboratory Sciences, Lund University, Sweden